C1QC and melanoma: TREM2+ TAMs from ESCC exhibited a consistent expression pattern and identical signature genes (TREM2, SPP1, APOE, C1QC, C1QB, and C1QA) with melanoma cells, suggesting that TREM2+ TAMs were associated with immunotherapy resistance in ESCC.